ZA200403220B - Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification. - Google Patents

Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification. Download PDF

Info

Publication number
ZA200403220B
ZA200403220B ZA200403220A ZA200403220A ZA200403220B ZA 200403220 B ZA200403220 B ZA 200403220B ZA 200403220 A ZA200403220 A ZA 200403220A ZA 200403220 A ZA200403220 A ZA 200403220A ZA 200403220 B ZA200403220 B ZA 200403220B
Authority
ZA
South Africa
Prior art keywords
composition
alkali metal
carbonate
ammonium
hydrocarbonate
Prior art date
Application number
ZA200403220A
Other languages
English (en)
Inventor
Zoltan Dardai
Original Assignee
Zoltan Dardai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoltan Dardai filed Critical Zoltan Dardai
Publication of ZA200403220B publication Critical patent/ZA200403220B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200403220A 2001-11-16 2004-04-29 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification. ZA200403220B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0104968A HU227496B1 (en) 2001-11-16 2001-11-16 Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis

Publications (1)

Publication Number Publication Date
ZA200403220B true ZA200403220B (en) 2004-07-28

Family

ID=50701118

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200403220A ZA200403220B (en) 2001-11-16 2004-04-29 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification.

Country Status (11)

Country Link
US (1) US20050004084A1 (de)
EP (1) EP1446160B1 (de)
CN (1) CN100342913C (de)
AT (1) ATE390934T1 (de)
CA (1) CA2465334A1 (de)
DE (1) DE60225939D1 (de)
EA (1) EA200400650A1 (de)
HU (1) HU227496B1 (de)
UA (1) UA82472C2 (de)
WO (1) WO2003041743A1 (de)
ZA (1) ZA200403220B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050074503A1 (en) * 2003-10-05 2005-04-07 Brilman Yakov Yevseyevich Bilious balsam
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
ES2525766B1 (es) * 2013-06-24 2015-10-13 Linguaversal S.L. Sistema y método para mejorar la percepción de los sonidos de un idioma extranjero
EP4112043A1 (de) * 2021-06-30 2023-01-04 GSK Consumer Healthcare SARL Nanokomplexzusammensetzung mit diclofenac

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL44774A (en) * 1974-05-06 1977-07-31 Baron E Pharmaceutical composition containing acetyl salicyclic acid
US4275059A (en) * 1977-03-28 1981-06-23 The Procter & Gamble Company Salicylate anti-inflammatory composition
US5037648A (en) * 1989-11-20 1991-08-06 Joiner Evelyn S Skin conditioning preparation having a pH above 7, method and method of making
US5140068A (en) * 1990-04-27 1992-08-18 The B. F. Goodrich Company Epoxy resin systems modified with low viscosity statistical monofunctional reactive polymers
US5176918A (en) * 1990-12-20 1993-01-05 Jones Jeffry L Topical medicament
US5612382A (en) * 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
US6419935B1 (en) * 1998-07-30 2002-07-16 L'oreal S.A. Cosmetic skin treatment method and cleansing treatment patch
HU9902296D0 (en) * 1999-07-07 1999-10-28 Dardai Pharmaceutical composition for treating caltification
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers

Also Published As

Publication number Publication date
UA82472C2 (uk) 2008-04-25
US20050004084A1 (en) 2005-01-06
WO2003041743A1 (en) 2003-05-22
HUP0104968A2 (hu) 2004-05-28
CN100342913C (zh) 2007-10-17
DE60225939D1 (de) 2008-05-15
HU227496B1 (en) 2011-07-28
HK1071056A1 (en) 2005-07-08
EP1446160A1 (de) 2004-08-18
EP1446160B1 (de) 2008-04-02
CA2465334A1 (en) 2003-05-22
HUP0104968D0 (en) 2002-01-28
EA200400650A1 (ru) 2004-10-28
CN1610558A (zh) 2005-04-27
ATE390934T1 (de) 2008-04-15

Similar Documents

Publication Publication Date Title
US5750141A (en) Administration of vaso-active agent and therapeutic agent
EP1737429B1 (de) Transdermale abgabe von vorteilhaften substanzen, beeinflusst von einer umgebung mit hoher ionenstärke
CN101506143B (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药
EP0104037B1 (de) Entzündungshemmendes und analgetisches Gel
PT1510213E (pt) Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona
KR19980081238A (ko) 약학 제형
US8771712B2 (en) Topical administration of acyclovir
US4039664A (en) Topical griseofulvin composition and method
BR112019001081B1 (pt) Composição tópica e usos da composição
JPH0768147B2 (ja) 経皮吸収増強組成物
JPH08175986A (ja) 経皮活性を示す５−アミノレブリン酸含有薬学組成物
ES2470367T3 (es) Preparaciones farmacéuticas para uso transd�rmico
EP1446160B1 (de) Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung
US5900412A (en) Percutaneous/transdermal delivery of ASA and antithrombotic therapies based thereon
AU2002339209A1 (en) Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
HK1071056B (en) Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
ES2201941B1 (es) Tratamiento de quemaduras.
CN1968704B (zh) 局部用色甘酸制剂
RS50693B (sr) Stabilni farmaceutski gel diklofenak natrijuma
US20220401412A1 (en) Methods for palmar or plantar administration of pharmaceutical compositions
WO2001003774A2 (en) Pharmaceutical composition for the treatment of calcification
EP3463478A1 (de) Topische pharmazeutische formulierung
JP2002504914A (ja) 局所的投与のために定められたジクロフェナク溶液
AU2001287706A1 (en) Treatment of burns
WO2025077886A1 (zh) 治疗和/或预防日光性角化病的化合物及方法